EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Circulating neutrophil extracellular traps in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism

Ronald H L Li iD, Arianne Fabella, Nghi Nguyen, Joanna L Kaplan, Eric Ontiveros, Joshua A Stern

Journal of Veterinary Internal Medicine · 2023

DOI: 10.1111/jvim.16676 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, 2023. Written by Ronald H L Li and 5 co-authors. Institution: Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, California, USA. Major MEDLINE topics: Extracellular Traps, Cardiomyopathy, Hypertrophic, Thromboembolism, Cat Diseases. Cited 20 times so far (Crossref); 49 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Morris Animal Foundation.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Cats with hypertrophic cardiomyopathy (HCM) are at risk of cardiogenic arterial thromboembolism (CATE). Neutrophil extracellular traps (NETs) may be a potential biomarker and therapeutic target for cardiomyopathy in cats. Hypothesis/Objectives Characterize NETs in cats with HCM or CATE. We hypothesized that circulating NETs assessed in the form of cell-free DNA (cfDNA) and citrullinated histone H3 (citH3) are increased in cats with HCM and CATE and associated with reported predisposing factors for thrombus formation. Animals Eighty-five cats including client-owned cats with HCM and CATE and staff- and student-owned clinically healthy cats without HCM.

Methods

After echocardiographic evaluations, NETs were measured as cfDNA and citH3.

Results

Cats with CATE had significant increases in cfDNA (11.2 ng/μL; interquartile range [IQR], 8.1 to 29.6) compared to those without HCM (8.2 ng/μL; IQR, 5.7 to 11.7 μL; P = .01) and were responsible for 75% to 83% of cases with cfDNA fragments sized 100 to 2000 base pairs. Citrullinated histone 3, detected in 52% of cats with HCM (31.1 ng/mL; IQR, 16.9 to 29.8), was significantly lower than in those with CATE (48.2 ng/mL; IQR, 34.2 to 60.2; P = .007). The citH3 concentrations correlated significantly with reported risk factors of CATE, such as left atrial auricular velocity. Conclusions and Clinical Importance Neutrophil extracellualr traps, especially citH3, are increased in cats with HCM and CATE. They may serve as a novel therapeutic target and biomarker of thrombosis in cats with HCM.

Subjects

MeSH terms (MEDLINE)

Extracellular TrapsCardiomyopathy, HypertrophicThromboembolismCat DiseasesCatsAnimalsNeutrophilsHistonesBiomarkers

Author keywords

NETosiscell-free DNAfragment sizepeptidyl arginine deiminase 4

Substances

HistonesBiomarkers

Authors and institutions

  • Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
  • Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.

ORCID profiles: Ronald H L Li

Funding

  • Morris Animal Foundation

Cite

APA

Li, R. H. L., Fabella, A., Nguyen, N., Kaplan, J. L., Ontiveros, E., & Stern, J. A. (2023). Circulating neutrophil extracellular traps in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16676

Vancouver

Li RHL, Fabella A, Nguyen N, Kaplan JL, Ontiveros E, Stern JA. Circulating neutrophil extracellular traps in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16676

BibTeX
@article{Li2023,
  author = {Li, Ronald H L and Fabella, Arianne and Nguyen, Nghi and Kaplan, Joanna L and Ontiveros, Eric and Stern, Joshua A},
  title = {Circulating neutrophil extracellular traps in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2023},
  doi = {10.1111/jvim.16676}
}
Start for free →